New

Dacryocystitis Treatment Market

2021

Dacryocystitis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Oral Antibiotics, Systemic Antibiotics, Surgery, Other); Application (Acute Dacryocystitis, Chronic Dacryocystitis, Congenital Dacryocystitis, Other); End-user (Hospitals, Ambulatory Surgical Centers, Eye Care Centers, Retail Pharmacies, Drug Stores, Others.) and Geography

| Report Code: TIPRE00023211 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Dacryocystitis Treatment Market 2028 By Product, Application, End-user and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Dacryocystitis refers to an inflammation of the lacrimal gland (tear sac). It is caused due to obstruction within the nasolacrimal duct and subsequent stagnation in the lacrimal sac. These infections may be acute or chronic. Its symptom includes pain, redness, and swelling over the inner aspect of the lower eyelid and epiphora. These infections generally occur in infants and adults over the age of 40. The treatment choice depends on the indication of dacryocystitis, such as oral antibiotics, systemic antibiotics (in most complicated cases), and surgery for recurring infections.

MARKET SCOPE

The "Global Dacryocystitis Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the dacryocystitis treatment market with detailed market segmentation by product, application, end-user, and geography. The report provides key statistics on the market status of the leading dacryocystitis treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on product, the global dacryocystitis treatment market is segmented into oral antibiotics, systemic antibiotics, surgery and other.
  •  On the basis of application, the market is segmented into acute dacryocystitis, chronic dacryocystitis, congenital dacryocystitis and other.
  •  On the basis of end-users, the market is bifurcated into hospitals, ambulatory surgical centers, eye care centers, retail pharmacies, drug stores and others.

MARKET DYNAMICS
Drivers

  •   The increasing prevalence of eye infections and technological advancements drive the dacryocystitis treatment market.
  •   Growing clinical research and subsequent new product launches boosts the market growth.
  •   Scientific advancements in the developed economies fuel market growth.
  •   The rising surgical procedures associated with nasal and eye infections propel the market growth.

Restraints

  •   Low healthcare expenditure in developing economies
  •   Lack of patient awareness regarding various treatment procedures.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The dacryocystitis treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the dacryocystitis treatment market in these regions.

IMPACT OF COVID-19 ON DACRYOCYSTITIS TREATMENT MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The market experienced fluctuations due to worldwide lockdown, business shutdown, and trade restrictions. The cancellation of all non-urgent and elective surgical procedures led to a decreased patient pool. Moreover, to slow the virus transmission, people gathering at clinics and hospitals were avoided. However, as all infected patients were not able to get treatment hence, the market may experience slow growth in the future after the removal of restrictive measures.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the dacryocystitis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from dacryocystitis treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for dacryocystitis treatment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the dacryocystitis treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Pfizer
  •  Abbott Laboratories
  •  Glaxosmithkline
  •  Mylan
  •  Cipla
  •  FCI Ophthalmics
  •  Aurolab
  •  Kaneka
  •  Gunther Weiss Scientific Glass
  •  Bess Medizintechnik GmbH

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dacryocystitis Treatment Market - By Product
1.3.2 Dacryocystitis Treatment Market - By Application
1.3.3 Dacryocystitis Treatment Market - By End-user
1.3.4 Dacryocystitis Treatment Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. DACRYOCYSTITIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. DACRYOCYSTITIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. DACRYOCYSTITIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. DACRYOCYSTITIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. DACRYOCYSTITIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. DACRYOCYSTITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ORAL ANTIBIOTICS
7.3.1. Overview
7.3.2. Oral Antibiotics Market Forecast and Analysis
7.4. SYSTEMIC ANTIBIOTICS
7.4.1. Overview
7.4.2. Systemic Antibiotics Market Forecast and Analysis
7.5. SURGERY
7.5.1. Overview
7.5.2. Surgery Market Forecast and Analysis
7.6. OTHER
7.6.1. Overview
7.6.2. Other Market Forecast and Analysis
8. DACRYOCYSTITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ACUTE DACRYOCYSTITIS
8.3.1. Overview
8.3.2. Acute Dacryocystitis Market Forecast and Analysis
8.4. CHRONIC DACRYOCYSTITIS
8.4.1. Overview
8.4.2. Chronic Dacryocystitis Market Forecast and Analysis
8.5. CONGENITAL DACRYOCYSTITIS
8.5.1. Overview
8.5.2. Congenital Dacryocystitis Market Forecast and Analysis
8.6. OTHER
8.6.1. Overview
8.6.2. Other Market Forecast and Analysis
9. DACRYOCYSTITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. AMBULATORY SURGICAL CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.5. EYE CARE CENTERS
9.5.1. Overview
9.5.2. Eye Care Centers Market Forecast and Analysis
9.6. RETAIL PHARMACIES
9.6.1. Overview
9.6.2. Retail Pharmacies Market Forecast and Analysis
9.7. DRUG STORES
9.7.1. Overview
9.7.2. Drug Stores Market Forecast and Analysis
9.8. OTHERS.
9.8.1. Overview
9.8.2. Others. Market Forecast and Analysis

10. DACRYOCYSTITIS TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Dacryocystitis Treatment Market Overview
10.1.2 North America Dacryocystitis Treatment Market Forecasts and Analysis
10.1.3 North America Dacryocystitis Treatment Market Forecasts and Analysis - By Product
10.1.4 North America Dacryocystitis Treatment Market Forecasts and Analysis - By Application
10.1.5 North America Dacryocystitis Treatment Market Forecasts and Analysis - By End-user
10.1.6 North America Dacryocystitis Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 Canada Dacryocystitis Treatment Market
10.1.6.1.1 Canada Dacryocystitis Treatment Market by Product
10.1.6.1.2 Canada Dacryocystitis Treatment Market by Application
10.1.6.1.3 Canada Dacryocystitis Treatment Market by End-user
10.1.6.2 Mexico Dacryocystitis Treatment Market
10.1.6.2.1 Mexico Dacryocystitis Treatment Market by Product
10.1.6.2.2 Mexico Dacryocystitis Treatment Market by Application
10.1.6.2.3 Mexico Dacryocystitis Treatment Market by End-user
10.1.6.3 US Dacryocystitis Treatment Market
10.1.6.3.1 US Dacryocystitis Treatment Market by Product
10.1.6.3.2 US Dacryocystitis Treatment Market by Application
10.1.6.3.3 US Dacryocystitis Treatment Market by End-user
10.2. EUROPE
10.2.1 Europe Dacryocystitis Treatment Market Overview
10.2.2 Europe Dacryocystitis Treatment Market Forecasts and Analysis
10.2.3 Europe Dacryocystitis Treatment Market Forecasts and Analysis - By Product
10.2.4 Europe Dacryocystitis Treatment Market Forecasts and Analysis - By Application
10.2.5 Europe Dacryocystitis Treatment Market Forecasts and Analysis - By End-user
10.2.6 Europe Dacryocystitis Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Dacryocystitis Treatment Market
10.2.6.1.1 Germany Dacryocystitis Treatment Market by Product
10.2.6.1.2 Germany Dacryocystitis Treatment Market by Application
10.2.6.1.3 Germany Dacryocystitis Treatment Market by End-user
10.2.6.2 France Dacryocystitis Treatment Market
10.2.6.2.1 France Dacryocystitis Treatment Market by Product
10.2.6.2.2 France Dacryocystitis Treatment Market by Application
10.2.6.2.3 France Dacryocystitis Treatment Market by End-user
10.2.6.3 Italy Dacryocystitis Treatment Market
10.2.6.3.1 Italy Dacryocystitis Treatment Market by Product
10.2.6.3.2 Italy Dacryocystitis Treatment Market by Application
10.2.6.3.3 Italy Dacryocystitis Treatment Market by End-user
10.2.6.4 Spain Dacryocystitis Treatment Market
10.2.6.4.1 Spain Dacryocystitis Treatment Market by Product
10.2.6.4.2 Spain Dacryocystitis Treatment Market by Application
10.2.6.4.3 Spain Dacryocystitis Treatment Market by End-user
10.2.6.5 United Kingdom Dacryocystitis Treatment Market
10.2.6.5.1 United Kingdom Dacryocystitis Treatment Market by Product
10.2.6.5.2 United Kingdom Dacryocystitis Treatment Market by Application
10.2.6.5.3 United Kingdom Dacryocystitis Treatment Market by End-user
10.2.6.6 Rest of Europe Dacryocystitis Treatment Market
10.2.6.6.1 Rest of Europe Dacryocystitis Treatment Market by Product
10.2.6.6.2 Rest of Europe Dacryocystitis Treatment Market by Application
10.2.6.6.3 Rest of Europe Dacryocystitis Treatment Market by End-user
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Dacryocystitis Treatment Market Overview
10.3.2 Asia-Pacific Dacryocystitis Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Dacryocystitis Treatment Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Dacryocystitis Treatment Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Dacryocystitis Treatment Market Forecasts and Analysis - By End-user
10.3.6 Asia-Pacific Dacryocystitis Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Dacryocystitis Treatment Market
10.3.6.1.1 Australia Dacryocystitis Treatment Market by Product
10.3.6.1.2 Australia Dacryocystitis Treatment Market by Application
10.3.6.1.3 Australia Dacryocystitis Treatment Market by End-user
10.3.6.2 China Dacryocystitis Treatment Market
10.3.6.2.1 China Dacryocystitis Treatment Market by Product
10.3.6.2.2 China Dacryocystitis Treatment Market by Application
10.3.6.2.3 China Dacryocystitis Treatment Market by End-user
10.3.6.3 India Dacryocystitis Treatment Market
10.3.6.3.1 India Dacryocystitis Treatment Market by Product
10.3.6.3.2 India Dacryocystitis Treatment Market by Application
10.3.6.3.3 India Dacryocystitis Treatment Market by End-user
10.3.6.4 Japan Dacryocystitis Treatment Market
10.3.6.4.1 Japan Dacryocystitis Treatment Market by Product
10.3.6.4.2 Japan Dacryocystitis Treatment Market by Application
10.3.6.4.3 Japan Dacryocystitis Treatment Market by End-user
10.3.6.5 South Korea Dacryocystitis Treatment Market
10.3.6.5.1 South Korea Dacryocystitis Treatment Market by Product
10.3.6.5.2 South Korea Dacryocystitis Treatment Market by Application
10.3.6.5.3 South Korea Dacryocystitis Treatment Market by End-user
10.3.6.6 Rest of Asia-Pacific Dacryocystitis Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Dacryocystitis Treatment Market by Product
10.3.6.6.2 Rest of Asia-Pacific Dacryocystitis Treatment Market by Application
10.3.6.6.3 Rest of Asia-Pacific Dacryocystitis Treatment Market by End-user
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Dacryocystitis Treatment Market Overview
10.4.2 Middle East and Africa Dacryocystitis Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Dacryocystitis Treatment Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Dacryocystitis Treatment Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Dacryocystitis Treatment Market Forecasts and Analysis - By End-user
10.4.6 Middle East and Africa Dacryocystitis Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Dacryocystitis Treatment Market
10.4.6.1.1 South Africa Dacryocystitis Treatment Market by Product
10.4.6.1.2 South Africa Dacryocystitis Treatment Market by Application
10.4.6.1.3 South Africa Dacryocystitis Treatment Market by End-user
10.4.6.2 Saudi Arabia Dacryocystitis Treatment Market
10.4.6.2.1 Saudi Arabia Dacryocystitis Treatment Market by Product
10.4.6.2.2 Saudi Arabia Dacryocystitis Treatment Market by Application
10.4.6.2.3 Saudi Arabia Dacryocystitis Treatment Market by End-user
10.4.6.3 U.A.E Dacryocystitis Treatment Market
10.4.6.3.1 U.A.E Dacryocystitis Treatment Market by Product
10.4.6.3.2 U.A.E Dacryocystitis Treatment Market by Application
10.4.6.3.3 U.A.E Dacryocystitis Treatment Market by End-user
10.4.6.4 Rest of Middle East and Africa Dacryocystitis Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Dacryocystitis Treatment Market by Product
10.4.6.4.2 Rest of Middle East and Africa Dacryocystitis Treatment Market by Application
10.4.6.4.3 Rest of Middle East and Africa Dacryocystitis Treatment Market by End-user
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Dacryocystitis Treatment Market Overview
10.5.2 South and Central America Dacryocystitis Treatment Market Forecasts and Analysis
10.5.3 South and Central America Dacryocystitis Treatment Market Forecasts and Analysis - By Product
10.5.4 South and Central America Dacryocystitis Treatment Market Forecasts and Analysis - By Application
10.5.5 South and Central America Dacryocystitis Treatment Market Forecasts and Analysis - By End-user
10.5.6 South and Central America Dacryocystitis Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Dacryocystitis Treatment Market
10.5.6.1.1 Brazil Dacryocystitis Treatment Market by Product
10.5.6.1.2 Brazil Dacryocystitis Treatment Market by Application
10.5.6.1.3 Brazil Dacryocystitis Treatment Market by End-user
10.5.6.2 Argentina Dacryocystitis Treatment Market
10.5.6.2.1 Argentina Dacryocystitis Treatment Market by Product
10.5.6.2.2 Argentina Dacryocystitis Treatment Market by Application
10.5.6.2.3 Argentina Dacryocystitis Treatment Market by End-user
10.5.6.3 Rest of South and Central America Dacryocystitis Treatment Market
10.5.6.3.1 Rest of South and Central America Dacryocystitis Treatment Market by Product
10.5.6.3.2 Rest of South and Central America Dacryocystitis Treatment Market by Application
10.5.6.3.3 Rest of South and Central America Dacryocystitis Treatment Market by End-user

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. DACRYOCYSTITIS TREATMENT MARKET, KEY COMPANY PROFILES
12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT LABORATORIES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MYLAN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CIPLA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. FCI OPHTHALMICS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. AUROLAB
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. KANEKA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GUNTHER WEISS SCIENTIFIC GLASS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BESS MEDIZINTECHNIK GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer
2. Abbott Laboratories
3. Glaxosmithkline
4. Mylan
5. Cipla
6. FCI Ophthalmics
7. Aurolab
8. Kaneka
9. Gunther Weiss Scientific Glass
10. Bess Medizintechnik GmbH
TIPRE00023211
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.